SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ipsen Sells the North American1 Development and Marketing Rights for Apokyn® to Britannia Pharmaceuticals Limited, Achieving a Key Milestone in the Execution of its New North American Strategy